Understanding how Merkel cell carcinoma develops
Official title: Unraveling the regulatory circuits that drive Merkel cell carcinoma
Funded at University of Arizona · NIH-10911200 · Data updated 2026-11-12
This study is looking into how a virus can cause Merkel cell carcinoma, a type of skin cancer, by changing normal cells into cancerous ones, and it aims to find new ways to understand and treat this condition better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | August 10, 2021 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $324,802 |
| NIH project number | 5R01CA251729-04 |
| Project ID | NIH-10911200 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Merkel cell carcinoma or those at high risk due to viral infections.
✕Less likely to help
Patients with other types of skin cancer or those not affected by Merkel cell polyomavirus may not benefit from this research.
What this research studies
This research investigates the mechanisms behind Merkel cell carcinoma (MCC), a type of skin cancer linked to a viral infection. By studying how specific viral oncogenes influence normal cells to become cancerous, researchers aim to uncover the molecular changes that lead to tumor formation and metastasis. The approach involves using advanced techniques to measure gene expression and observe the sequence of events that occur during carcinogenesis, providing insights that traditional methods cannot offer. This could lead to a better understanding of MCC and potential new treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with Merkel cell carcinoma.
How similar studies have gone: Previous research has shown promise in understanding cancer mechanisms through viral interactions, suggesting potential for success in this novel approach.
Where this research is happening
-
University of Arizona
Tucson, United States Active
Researchers
- Principal investigator: Padi, Megha — University of Arizona
- Study coordinator: Padi, Megha
Related research
Other NIH-funded projects on the same topics.
-
Immunobiology and Immunotherapy for Merkel Cell Carcinoma
A team at the University of Washington is advancing how the immune system fights a rare skin cancer called Merkel cell carcinoma and testing new immune-based treatments to help patients who don’t respond to existing therapies.
-
New therapies for Merkel cell carcinoma and its immune environment
A cancer grant is testing a drug that may boost immune therapies and help patients with Merkel cell carcinoma who don’t respond to current treatments.
-
Understanding how Merkel cell skin cancer develops
This research explores how a specific virus causes Merkel cell carcinoma, a rare and aggressive skin cancer.
-
New treatments for Merkel cell carcinoma
This research looks for new ways to treat Merkel cell carcinoma, a serious skin cancer, especially for patients who don't respond to current therapies.
-
Immune therapies for Merkel cell carcinoma
This project develops and tests new immune-based treatments to help people with Merkel cell carcinoma, especially those whose cancers no longer respond to PD‑1 drugs.
-
Investigating a new treatment for Merkel cell carcinoma
This study is looking at a type of skin cancer called Merkel cell carcinoma, especially in older Veterans, to see how a specific protein affects the cancer and to test a new treatment that could help those who can't use current therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.